Trial Profile
The effective of the triple therapy for clarithromycin-resistant Helicobacter pylori using Vonoprazan,AMPC,MNZ.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 07 Feb 2017
Price :
$35
*
At a glance
- Drugs Amoxicillin (Primary) ; Metronidazole (Primary) ; Vonoprazan (Primary)
- Indications Helicobacter pylori infections
- Focus Therapeutic Use
- 03 Feb 2017 Status changed from not yet recruiting to discontinued.
- 30 May 2016 New trial record